StonvexLoading…
StonvexStonvexStonvexCore line items from BV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.67B | $2.77B | $2.82B | $2.77B |
Operating Income | $134.60M | $156.90M | $101.00M | $88.40M |
Net Income | $56.00M | $66.40M | $-7.70M | $14.00M |
EPS (Diluted) | $0.13 | $0.20 | $-0.12 | $0.14 |
Total Assets | $3.39B | $3.39B | $3.35B | $3.31B |
Total Liabilities | $1.59B | $1.61B | $1.61B | $2.09B |
Cash & Equivalents | $74.50M | $140.40M | $67.00M | $20.10M |
Free Cash Flow OCF − CapEx | $37.60M | $127.20M | $58.60M | $-400.00K |
Shares Outstanding | 94.80M | 94.80M | 93.60M | 93.00M |